Skip to content

Clinical Efficacy Observation of the Treatment of Anshen Tongluo Acupuncture on Fibromyalgia

Clinical Efficacy Observation of the Treatment of Anshen Tongluo Acupuncture on Fibromyalgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070075
Enrollment
Unknown
Registered
2023-03-31
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Interventions

Electroacupuncture Group:Electroacupuncture
Sham electroacupuncture Group:Sham electroacupuncture

Sponsors

Wenzhou Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1 according with the diagnostic standard of fibromyalgia syndrome; 2 between 15-65 years old; 3 volunteer and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1 patients with contraindication of acupuncture manipulation, such as severe bleeding tendency disease, pregnant women, etc. , who are not suitable for acupuncture treatment; 2 patients with severe heart failure, liver and kidney failure and other basic diseases, which affect the assessment of therapeutic effect; 3 patients with severe cognitive impairment; 4 patients who did not believe in acupuncture treatment or feared acupuncture; 5 patients with other diseases and unstable vital signs, although they were in accordance with the diagnosis of the disease.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale, VAS;

Secondary

MeasureTime frame
FIQR;Number of tenderness points;SF-36;

Countries

China

Contacts

Public ContactSong Fengjun

Wenzhou Hospital of Traditional Chinese Medicine

546832696@qq.com13955763813

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026